131 related articles for article (PubMed ID: 2628072)
1. Characterization of a human tumour cell line panel for screening of anti-tumour agents in vitro.
Fricker SP; Buckley RG
Biochem Soc Trans; 1989 Dec; 17(6):1049-50. PubMed ID: 2628072
[No Abstract] [Full Text] [Related]
2. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
Kirkpatrick DL; Duke M; Goh TS
Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
Pieters R; Huismans DR; Leyva A; Veerman AJ
Br J Cancer; 1989 Feb; 59(2):217-20. PubMed ID: 2930687
[No Abstract] [Full Text] [Related]
4. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
Carmichael J; Mitchell JB; DeGraff WG; Gamson J; Gazdar AF; Johnson BE; Glatstein E; Minna JD
Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
6. [A tumor sensitivity test, SDI test using XTT].
Kondo T; Tatematsu A; Sato Y; Ishikawa M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):123-6. PubMed ID: 1987893
[No Abstract] [Full Text] [Related]
7. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Sobottka SB; Berger MR
Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
[TBL] [Abstract][Full Text] [Related]
8. The clinical benefit of the histoculture drug response assay.
Hoffman RM
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():321-2. PubMed ID: 10895174
[No Abstract] [Full Text] [Related]
9. The hollow fiber assay.
Hall LA; Krauthauser CM; Wexler RS; Slee AM; Kerr JS
Methods Mol Med; 2003; 74():545-66. PubMed ID: 12415720
[No Abstract] [Full Text] [Related]
10. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the relative cytotoxic effects of anticancer agents in serum-supplemented versus serum-free media using a tetrazolium colorimetric assay.
Tsai CM; Perng RP; Chang KT; Venzon D; Gazdar AF
Jpn J Cancer Res; 1996 Jan; 87(1):91-7. PubMed ID: 8609055
[TBL] [Abstract][Full Text] [Related]
12. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
[TBL] [Abstract][Full Text] [Related]
13. [Estimating doses of anti-cancer agents in sensitivity tests in vitro].
Kobayashi K; Takemoto T; Hino M; Hayashihara K; Nakahiro K; Wasai S; Niitani H
Gan To Kagaku Ryoho; 1992 Mar; 19(3):399-403. PubMed ID: 1543368
[No Abstract] [Full Text] [Related]
14. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
15. [Sensitivity test of anti-tumor agents. 2. Application of MTT assay].
Wada Y; Tomiyoshi Y; Fujimaru J; Ogura M; Yoshida S; Takeda Y
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1587-92. PubMed ID: 1908212
[TBL] [Abstract][Full Text] [Related]
16. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
Shimoyama Y; Kubota T; Watanabe M; Ishibiki K; Abe O
J Surg Oncol; 1989 May; 41(1):12-8. PubMed ID: 2716329
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activity of indolyl thiazoles.
Moody CJ; Roffey JR; Stephens MA; Stratford IJ
Anticancer Drugs; 1997 Jun; 8(5):489-99. PubMed ID: 9215613
[TBL] [Abstract][Full Text] [Related]
18. [Chemosensitivity test for thyroid cancer by in vitro MTT assay].
Sasaki F; Ishimura H; Takada N; Uchino J
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1777-81. PubMed ID: 7574809
[TBL] [Abstract][Full Text] [Related]
19. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.
Etievant C; Kruczynski A; Pauwels O; Kiss R
Anticancer Res; 1991; 11(1):305-11. PubMed ID: 2018364
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
Fricker SP; Buckley RG
Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
